NO971890D0 - Orale cyklosporinformuleringer - Google Patents

Orale cyklosporinformuleringer

Info

Publication number: NO971890D0
Authority: NO; Norway
Prior art keywords: oral cyclosporine; cyclosporine formulations; formulations; oral; cyclosporine
Prior art date: 1995-08-25

Application number

NO971890A

Other languages

English (en)

Norwegian (no)

Other versions

NO971890L (no

Inventor

Moo J Cho

Ralph E Levy

Philippe J Pouletty

H Robert Floc

Christian Merle

Original Assignee

Sangstat Medical Corp

Univ North Carolina

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-25

Filing date

1997-04-24

Publication date

1997-04-24

1995-08-25 Priority claimed from US08/519,689 external-priority patent/US5834017A/en

1996-03-21 Priority claimed from US08/620,021 external-priority patent/US5766629A/en

1996-03-25 Priority claimed from US08/622,516 external-priority patent/US5827822A/en

1997-04-24 Application filed by Sangstat Medical Corp, Univ North Carolina filed Critical Sangstat Medical Corp

1997-04-24 Publication of NO971890L publication Critical patent/NO971890L/no

1997-04-24 Publication of NO971890D0 publication Critical patent/NO971890D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Dispersion Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

NO971890A 1995-08-25 1997-04-24 Orale cyklosporinformuleringer NO971890D0 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US08/519,689 US5834017A (en)	1995-08-25	1995-08-25	Oral cyclopsporin formulations
US08/620,021 US5766629A (en)	1995-08-25	1996-03-21	Oral cyclosporin formulations
US08/622,516 US5827822A (en)	1996-03-25	1996-03-25	Cyclosporin a formulations as nanoparticles
PCT/US1996/012569 WO1997007787A1 (fr)	1995-08-25	1996-07-31	Compositions orales de cyclosporine

Publications (2)

Publication Number	Publication Date
NO971890L NO971890L (no)	1997-04-24
NO971890D0 true NO971890D0 (no)	1997-04-24

Family

ID=27414735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO971890A NO971890D0 (no)	1995-08-25	1997-04-24	Orale cyklosporinformuleringer

Country Status (27)

Country	Link
EP (1)	EP0789561B1 (fr)
JP (1)	JP3009742B2 (fr)
KR (1)	KR100294935B1 (fr)
CN (1)	CN1164828A (fr)
AR (1)	AR001985A1 (fr)
AT (1)	ATE263550T1 (fr)
AU (1)	AU709548B2 (fr)
BG (1)	BG62875B1 (fr)
BR (1)	BR9606603A (fr)
CA (1)	CA2202887A1 (fr)
CZ (1)	CZ124897A3 (fr)
DE (2)	DE789561T1 (fr)
ES (1)	ES2129381T1 (fr)
GE (1)	GEP20012547B (fr)
HK (1)	HK1001956A1 (fr)
HU (1)	HUP9801052A3 (fr)
IL (1)	IL120673A0 (fr)
IS (1)	IS4460A (fr)
MX (1)	MX9702809A (fr)
NO (1)	NO971890D0 (fr)
NZ (1)	NZ313899A (fr)
PL (1)	PL319898A1 (fr)
RO (1)	RO119815B1 (fr)
SI (1)	SI9620014A (fr)
SK (1)	SK53697A3 (fr)
TW (1)	TW460287B (fr)
WO (1)	WO1997007787A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5962019A (en) *	1995-08-25	1999-10-05	Sangstat Medical Corporation	Oral cyclosporin formulations
US6008192A (en) *	1997-03-12	1999-12-28	Abbott Laboratories	Hydrophilic binary systems for the administration of lipophilic compounds
CA2306448A1 (fr)	1997-10-16	1999-04-22	Board Of Regents, The University Of Texas System	Modeles et traitement de l'hypertrophie cardiaque en liaison avec la fonction nf-at3
US6656504B1 (en) *	1999-09-09	2003-12-02	Elan Pharma International Ltd.	Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
NZ531946A (en) *	2001-10-19	2005-09-30	Isotechnika Inc	Preconcentrate formulations comprising cyclosporin analogue microemulsions that reduce adverse effects while maintaining high bioavailability
WO2008122965A2 (fr)	2007-04-04	2008-10-16	Sigmoid Pharma Limited	Compositions pharmaceutiques à base de cyclosporine
CA2685118C (fr)	2007-04-26	2016-11-01	Sigmoid Pharma Limited	Fabrication de minicapsules multiples
US20090130198A1 (en) *	2007-11-21	2009-05-21	Innopharmax Inc.	Pharmaceutical composition with enhanced bioavailability
SI2432455T1 (sl)	2009-05-18	2015-04-30	Sigmoid Pharma Limited	Sestava, obsegajoäśa oljne kapljice
EP2464341B1 (fr)	2009-08-12	2022-07-06	Sublimity Therapeutics Limited	Compositions immunomodulatrices comprenant une matrice polymère et une phase huileuse
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201304662D0 (en)	2013-03-14	2013-05-01	Sigmoid Pharma Ltd	Compositions
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
WO2016071515A1 (fr)	2014-11-07	2016-05-12	Sigmoid Pharma Limited	Compositions comprenant de la cyclosporine
CN104940132B (zh) *	2015-06-05	2018-02-27	河南牧翔动物药业有限公司	一种硫酸小檗碱口服液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE445174B (sv) *	1978-03-07	1986-06-09	Sandoz Ag	Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
HU201567B (en) *	1988-07-21	1990-11-28	Gyogyszerkutato Intezet	Process for production of intravenous medical compositions containing cyclosphorin
US5342625A (en) *	1988-09-16	1994-08-30	Sandoz Ltd.	Pharmaceutical compositions comprising cyclosporins
HU208491B (en) *	1990-11-27	1993-11-29	Gyogyszerkutato Intezet	Process for producing oral pharmaceutical composition containing cyclosporin
EP1142568A1 (fr) *	1992-09-25	2001-10-10	Novartis AG	Compositions pharmaceutiques à base de cyclosporines
DE4340781C3 (de) *	1993-11-30	2000-01-27	Novartis Ag	Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
PT789580E (pt) *	1994-11-03	2002-09-30	Novartis Ag	Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao

1996
- 1996-07-31 CA CA002202887A patent/CA2202887A1/fr not_active Abandoned
- 1996-07-31 GE GEAP19963706A patent/GEP20012547B/en unknown
- 1996-07-31 MX MX9702809A patent/MX9702809A/es unknown
- 1996-07-31 HU HU9801052A patent/HUP9801052A3/hu unknown
- 1996-07-31 ES ES96926214T patent/ES2129381T1/es active Pending
- 1996-07-31 SK SK536-97A patent/SK53697A3/sk unknown
- 1996-07-31 SI SI9620014A patent/SI9620014A/sl unknown
- 1996-07-31 CZ CZ971248A patent/CZ124897A3/cs unknown
- 1996-07-31 JP JP9510271A patent/JP3009742B2/ja not_active Expired - Fee Related
- 1996-07-31 AU AU66441/96A patent/AU709548B2/en not_active Withdrawn - After Issue
- 1996-07-31 CN CN96190962A patent/CN1164828A/zh active Pending
- 1996-07-31 WO PCT/US1996/012569 patent/WO1997007787A1/fr active IP Right Grant
- 1996-07-31 DE DE0789561T patent/DE789561T1/de active Pending
- 1996-07-31 RO RO97-00765A patent/RO119815B1/ro unknown
- 1996-07-31 AT AT96926214T patent/ATE263550T1/de not_active IP Right Cessation
- 1996-07-31 PL PL96319898A patent/PL319898A1/xx unknown
- 1996-07-31 IL IL12067396A patent/IL120673A0/xx unknown
- 1996-07-31 BR BR9606603A patent/BR9606603A/pt not_active IP Right Cessation
- 1996-07-31 DE DE69632125T patent/DE69632125T2/de not_active Expired - Fee Related
- 1996-07-31 EP EP96926214A patent/EP0789561B1/fr not_active Expired - Lifetime
- 1996-07-31 NZ NZ313899A patent/NZ313899A/xx unknown
- 1996-07-31 KR KR1019970702717A patent/KR100294935B1/ko not_active IP Right Cessation
- 1996-08-23 AR ARP960104092A patent/AR001985A1/es unknown
- 1996-09-23 TW TW085111622A patent/TW460287B/zh not_active IP Right Cessation
1997
- 1997-04-08 IS IS4460A patent/IS4460A/is unknown
- 1997-04-24 NO NO971890A patent/NO971890D0/no not_active Application Discontinuation
- 1997-04-25 BG BG101443A patent/BG62875B1/bg unknown
1998
- 1998-02-10 HK HK98101006A patent/HK1001956A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO971890L (no)	1997-04-24
BR9606603A (pt)	1997-09-30
EP0789561A1 (fr)	1997-08-20
CN1164828A (zh)	1997-11-12
WO1997007787A1 (fr)	1997-03-06
DE789561T1 (de)	1999-06-10
EP0789561B1 (fr)	2004-04-07
SK53697A3 (en)	1997-10-08
DE69632125T2 (de)	2004-09-16
DE69632125D1 (de)	2004-05-13
BG101443A (en)	1998-03-31
AU709548B2 (en)	1999-09-02
GEP20012547B (en)	2001-10-25
PL319898A1 (en)	1997-09-01
RO119815B1 (ro)	2005-04-29
NZ313899A (en)	2000-03-27
MX9702809A (es)	1998-02-28
KR970706803A (ko)	1997-12-01
CA2202887A1 (fr)	1997-03-06
EP0789561A4 (fr)	1998-12-02
AR001985A1 (es)	1998-01-07
IL120673A0 (en)	1997-08-14
JPH10509462A (ja)	1998-09-14
TW460287B (en)	2001-10-21
AU6644196A (en)	1997-03-19
IS4460A (is)	1997-04-08
BG62875B1 (bg)	2000-10-31
HUP9801052A3 (en)	1998-12-28
HK1001956A1 (en)	1998-07-24
SI9620014A (sl)	1998-04-30
ATE263550T1 (de)	2004-04-15
JP3009742B2 (ja)	2000-02-14
CZ124897A3 (en)	1997-09-17
KR100294935B1 (ko)	2001-07-12
ES2129381T1 (es)	1999-06-16
HUP9801052A2 (hu)	1998-09-28

Publication	Publication Date	Title
NO993096D0 (no)	1999-06-22	Orale cyklosporinformuleringer
DK1093815T3 (da)	2005-04-25	Oral 2-methyl-thieno-benzodiazepinformulering
BR9610153A (pt)	1999-01-05	Formulações farmacêuticas
BR9611626A (pt)	1999-06-01	Formulações farmacéuticas
EE9800123A (et)	1998-10-15	Stabiilsed lüofiliseeritud ravimvormid
DE69518331D1 (de)	2000-09-14	Orale zubereitungen
FI974241A0 (fi)	1997-11-14	BPM-15 -koostumukset
MA24473A1 (fr)	1998-10-01	Formulations
NO962490D0 (no)	1996-06-12	Orale formuleringer av S(+)-ibuprofen
DE59506139D1 (de)	1999-07-15	Orale Retard-Präparation
ID19097A (id)	1998-06-11	Komposisi-komposisi oral
NO962491D0 (no)	1996-06-12	Orale formuleringer av S(+)-etodolac
NO981568D0 (no)	1998-04-06	Randtennings-tennsatssammensetninger
ATE263550T1 (de)	2004-04-15	Orale cyclosporinformulierungen
DE69617029D1 (de)	2001-12-20	Organoton-zusammensetzungen
ITMI951395A0 (it)	1995-06-29	Formulazioni di f-silicone
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
DE69432149D1 (de)	2003-03-27	Orale Zubereitungen
TR199501082A2 (tr)	1996-06-21	Farmasötik formülasyonlar.
DK0861025T3 (da)	2004-05-10	Pesticidformuleringer
ITMI941169A0 (it)	1994-06-06	Formulazioni farmaceutiche
NO996044L (no)	1999-12-08	Rapamycinformuleringer for oral administrasjon
BR9606974A (pt)	1997-11-04	Composições orais
DE69603228D1 (de)	1999-08-19	Aluminoxanate-Zusammensetzungen
ATE206150T1 (de)	2001-10-15	Farbstoffstabilisierte zusammensetzungen

Legal Events

Date	Code	Title	Description
2003-03-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application